Over two-thirds of biopharmaceutical manufacturers now report that their facility is experiencing capacity bottlenecks due to downstream processing. A number of factors continue to converge to create ...
Alternatives to Traditional Unit Operations Are Now Available to Alleviate Very Real Logjams Due to the complexity of therapeutic protein purification, downstream bioprocess bottlenecks can arise from ...
mRNA plasmid-based DNA vaccines, and advanced modalities using viral vectors, are at the forefront of the fight against cancer, cardiovascular, immunological, and infectious diseases. To reach their ...
From food and pharmaceutical products to chemicals and fuels, bioprocessing involves harnessing the properties of living cells and their components to create useful products. These can be anything ...
The biopharmaceutical market is driving the revolution from traditional batch processes to continuous manufacturing for higher productivity and lower costs. In this work, a batch mAb downstream ...
With multiple, complex chromatographic purification, buffer exchange, and viral inactivation steps, downstream processing of monoclonal antibodies (mAbs) remains the major bottleneck in ...
The demand for improving global access to innovative, life-saving drugs is rising. This places mounting pressure on biopharmaceutical developers and manufacturers to deliver effective biotherapeutics, ...
The goal of this work is to develop a downstream process for the purification of human growth hormone (hGH) and an hGH antagonist, named hGHG120R, from cultured recombinant mouse L cells grown in the ...
Pilot Plant Downstream Process Produces Lithium Carbonate with 99.78% Purity CleanTech Lithium PLC (AIM: CTL, Frankfurt: T2N), an exploration and development company advancing sustainable lithium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback